| 4874 |
Patient Helpdesk |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4878 |
Recommended Supervisory Visits |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4880 |
Joint Supportive Supervision Mission |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4881 |
Nikshay Data Policy for Monitoring and Review: Outcome |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4882 |
Nikshay Data Policy for Monitoring and Review |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4883 |
Review Meeting Protocols- District Level/ Block Level/ Village level |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4884 |
Review Meeting Protocols- State Level |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4885 |
Monitoring – Know how’s |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4886 |
Levels of Monitoring |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4923 |
Control, Elimination and Eradication |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 4926 |
Pleural TB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5043 |
Lymph node Tuberculosis [LNTB] |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5044 |
Epidemiology of LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5045 |
Pathogenesis of LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5046 |
Clinical Presentation of LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5047 |
Approach to Lymphadenopathy in LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5048 |
Investigations for LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5049 |
Microbiological confirmation in LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5050 |
Management of LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5051 |
Follow up in Treatment of LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5052 |
LNTB Clinical Scenarios |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5053 |
Response to Treatment in LNTB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5088 |
Cutaneous TB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5089 |
Presumptive Cutaneous TB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5090 |
Lupus vulgaris |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5091 |
Scrofuloderma |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5092 |
Tuberculosis verrucosa cutis |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5093 |
Diagnosis of Cutaneous TB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5094 |
Management and follow-up of cutaneous TB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 5128 |
ENT TB Clinical Scenarios |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
